SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurinia Pharmaceuticals Inc. - AUPH Pharmaceutical Investing
Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers Pharmaceutical Investing
Bloom Health Partners Completes Fiscal Q1 2022 with $5.8M in Revenue and Maintains Guidance for Full Fiscal Year Medical Device Investing
Thermo Fisher Scientific to Present at Cowen's 42nd Annual Healthcare Conference Medical Device Investing
Ortho Dermatologics Now Accepting Applications for 2022 Aspire Higher Scholarship Program Pharmaceutical Investing
Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV in Infants from Birth up to Six Months of Age by Active Immunization of Pregnant Women Life Science Investing
Bristol Myers Squibb Announces Early Participation Results, Upsizing and Early Settlement of Tender Offers Pharmaceutical Investing
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
